01 22NALPROPION
02 1TWI PHARMS
01 17375111
02 17462626
03 17674479
04 18088786
05 18318788
06 18722085
07 18815889
08 18916195
09 19107837
10 19125868
11 19248123
12 19633575
13 110231964
14 110307376
15 110403170
16 110828294
17 110835527
18 111033543
19 111139056
20 111278544
21 111324741
22 111998542
23 112048769
01 23Blank
01 3Y
02 20Blank
01 12024-04-21
02 22024-07-20
03 12025-03-26
04 12027-06-04
05 12027-06-25
06 52027-11-08
07 12029-02-03
08 12029-05-29
09 12030-02-02
10 12031-01-10
11 12032-01-13
12 22033-06-05
13 12033-06-25
14 42034-07-02
Patent Expiration Date : 2027-11-08
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8722085
Drug Substance Claim :
Drug Product Claim :
Application Number : 200063
Patent Use Code : U-1585
Delist Requested :
Patent Use Description : USE OF NALTREXONE AND ...
Patent Expiration Date : 2027-11-08
Patent Expiration Date : 2024-07-20
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8815889
Drug Substance Claim :
Drug Product Claim :
Application Number : 200063
Patent Use Code : U-1586
Delist Requested :
Patent Use Description : FOR EFFECT ON BLOOD GL...
Patent Expiration Date : 2024-07-20
Patent Expiration Date : 2027-06-04
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US Patent Number : 9107837
Drug Substance Claim :
Drug Product Claim :
Application Number : 200063
Patent Use Code : U-1639
Delist Requested :
Patent Use Description : USE OF NALTREXONE AND ...
Patent Expiration Date : 2027-06-04
Patent Expiration Date : 2027-11-08
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US Patent Number : 9125868
Drug Substance Claim :
Drug Product Claim :
Application Number : 200063
Patent Use Code : U-1585
Delist Requested :
Patent Use Description : USE OF NALTREXONE AND ...
Patent Expiration Date : 2027-11-08
Patent Expiration Date : 2034-07-02
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US Patent Number : 10231964
Drug Substance Claim :
Drug Product Claim :
Application Number : 200063
Patent Use Code : U-1583
Delist Requested :
Patent Use Description : FOR CHRONIC WEIGHT MAN...
Patent Expiration Date : 2034-07-02
Patent Expiration Date : 2024-07-20
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US Patent Number : 7462626
Drug Substance Claim :
Drug Product Claim :
Application Number : 200063
Patent Use Code : U-1583
Delist Requested :
Patent Use Description : FOR CHRONIC WEIGHT MAN...
Patent Expiration Date : 2024-07-20
Patent Expiration Date : 2027-11-08
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US Patent Number : 10307376
Drug Substance Claim :
Drug Product Claim :
Application Number : 200063
Patent Use Code : U-1585
Delist Requested :
Patent Use Description : USE OF NALTREXONE AND ...
Patent Expiration Date : 2027-11-08
Patent Expiration Date : 2034-07-02
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US Patent Number : 11998542
Drug Substance Claim :
Drug Product Claim :
Application Number : 200063
Patent Use Code : U-1583
Delist Requested :
Patent Use Description : FOR CHRONIC WEIGHT MAN...
Patent Expiration Date : 2034-07-02
Patent Expiration Date : 2033-06-05
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US Patent Number : 11139056
Drug Substance Claim :
Drug Product Claim :
Application Number : 200063
Patent Use Code : U-1583
Delist Requested :
Patent Use Description : FOR CHRONIC WEIGHT MAN...
Patent Expiration Date : 2033-06-05
Patent Expiration Date : 2033-06-05
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US Patent Number : 10403170
Drug Substance Claim :
Drug Product Claim :
Application Number : 200063
Patent Use Code : U-1583
Delist Requested :
Patent Use Description : FOR CHRONIC WEIGHT MAN...
Patent Expiration Date : 2033-06-05
LOOKING FOR A SUPPLIER?
